Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus

Roberto Fogari, Giuseppe Derosa, Annalisa Zoppi, Andrea Rinaldi, Paola Preti, Pierangelo Lazzari, Amedeo Mugellini

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to compare the combination treatments of manidipine/delapril and olmesartan/hydrochlorothiazide (HCTZ) in elderly diabetic hypertensives. After a 4-week placebo period, 158 hypertensive patients with type 2 diabetes (age range: 66 to 74 years) were randomized to receive combination treatment of 10 mg manidipine plus 30 mg delapril or 20 mg olmesartan plus 12.5 mg HCTZ for 48 weeks in a prospective, parallel arm trial. After 12 weeks, manidipine or HCTZ was doubled in nonresponders (systolic blood pressure [SBP] ≥130 mmHg and/ or diastolic blood pressure [DBP] ≥:80 mmHg). Patients were checked at the end of the placebo period and every 12 weeks thereafter. At each visit, lying, sitting and standing BP as well as fasting glycernia, glycosylated hemoglobin (HbA1c), electrolytes, uric acid, total cholesterol (TC), hlgh-densfty lipoprotein-cholesterol (HDL-C) and triglycerides (TG) were evaluated. Both combinations reduced sitting SBP (-27.7 and -28.3 mmHg, respectively; both p

Original languageEnglish
Pages (from-to)43-50
Number of pages8
JournalHypertension Research
Volume31
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

manidipine
Hydrochlorothiazide
Type 2 Diabetes Mellitus
Blood Pressure
Therapeutics
Placebos
Glycosylated Hemoglobin A
Uric Acid
Electrolytes
olmesartan
delapril
Fasting
Cholesterol

Keywords

  • Delapril
  • Diabetic hypertensives
  • Hydrochlorothiazide
  • Manidipine
  • Olmesartan

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus. / Fogari, Roberto; Derosa, Giuseppe; Zoppi, Annalisa; Rinaldi, Andrea; Preti, Paola; Lazzari, Pierangelo; Mugellini, Amedeo.

In: Hypertension Research, Vol. 31, No. 1, 01.2008, p. 43-50.

Research output: Contribution to journalArticle

@article{a6054a7dec904e81a1aa1ae8c53bcf81,
title = "Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus",
abstract = "The purpose of this study was to compare the combination treatments of manidipine/delapril and olmesartan/hydrochlorothiazide (HCTZ) in elderly diabetic hypertensives. After a 4-week placebo period, 158 hypertensive patients with type 2 diabetes (age range: 66 to 74 years) were randomized to receive combination treatment of 10 mg manidipine plus 30 mg delapril or 20 mg olmesartan plus 12.5 mg HCTZ for 48 weeks in a prospective, parallel arm trial. After 12 weeks, manidipine or HCTZ was doubled in nonresponders (systolic blood pressure [SBP] ≥130 mmHg and/ or diastolic blood pressure [DBP] ≥:80 mmHg). Patients were checked at the end of the placebo period and every 12 weeks thereafter. At each visit, lying, sitting and standing BP as well as fasting glycernia, glycosylated hemoglobin (HbA1c), electrolytes, uric acid, total cholesterol (TC), hlgh-densfty lipoprotein-cholesterol (HDL-C) and triglycerides (TG) were evaluated. Both combinations reduced sitting SBP (-27.7 and -28.3 mmHg, respectively; both p",
keywords = "Delapril, Diabetic hypertensives, Hydrochlorothiazide, Manidipine, Olmesartan",
author = "Roberto Fogari and Giuseppe Derosa and Annalisa Zoppi and Andrea Rinaldi and Paola Preti and Pierangelo Lazzari and Amedeo Mugellini",
year = "2008",
month = "1",
doi = "10.1291/hypres.31.43",
language = "English",
volume = "31",
pages = "43--50",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus

AU - Fogari, Roberto

AU - Derosa, Giuseppe

AU - Zoppi, Annalisa

AU - Rinaldi, Andrea

AU - Preti, Paola

AU - Lazzari, Pierangelo

AU - Mugellini, Amedeo

PY - 2008/1

Y1 - 2008/1

N2 - The purpose of this study was to compare the combination treatments of manidipine/delapril and olmesartan/hydrochlorothiazide (HCTZ) in elderly diabetic hypertensives. After a 4-week placebo period, 158 hypertensive patients with type 2 diabetes (age range: 66 to 74 years) were randomized to receive combination treatment of 10 mg manidipine plus 30 mg delapril or 20 mg olmesartan plus 12.5 mg HCTZ for 48 weeks in a prospective, parallel arm trial. After 12 weeks, manidipine or HCTZ was doubled in nonresponders (systolic blood pressure [SBP] ≥130 mmHg and/ or diastolic blood pressure [DBP] ≥:80 mmHg). Patients were checked at the end of the placebo period and every 12 weeks thereafter. At each visit, lying, sitting and standing BP as well as fasting glycernia, glycosylated hemoglobin (HbA1c), electrolytes, uric acid, total cholesterol (TC), hlgh-densfty lipoprotein-cholesterol (HDL-C) and triglycerides (TG) were evaluated. Both combinations reduced sitting SBP (-27.7 and -28.3 mmHg, respectively; both p

AB - The purpose of this study was to compare the combination treatments of manidipine/delapril and olmesartan/hydrochlorothiazide (HCTZ) in elderly diabetic hypertensives. After a 4-week placebo period, 158 hypertensive patients with type 2 diabetes (age range: 66 to 74 years) were randomized to receive combination treatment of 10 mg manidipine plus 30 mg delapril or 20 mg olmesartan plus 12.5 mg HCTZ for 48 weeks in a prospective, parallel arm trial. After 12 weeks, manidipine or HCTZ was doubled in nonresponders (systolic blood pressure [SBP] ≥130 mmHg and/ or diastolic blood pressure [DBP] ≥:80 mmHg). Patients were checked at the end of the placebo period and every 12 weeks thereafter. At each visit, lying, sitting and standing BP as well as fasting glycernia, glycosylated hemoglobin (HbA1c), electrolytes, uric acid, total cholesterol (TC), hlgh-densfty lipoprotein-cholesterol (HDL-C) and triglycerides (TG) were evaluated. Both combinations reduced sitting SBP (-27.7 and -28.3 mmHg, respectively; both p

KW - Delapril

KW - Diabetic hypertensives

KW - Hydrochlorothiazide

KW - Manidipine

KW - Olmesartan

UR - http://www.scopus.com/inward/record.url?scp=40149087517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40149087517&partnerID=8YFLogxK

U2 - 10.1291/hypres.31.43

DO - 10.1291/hypres.31.43

M3 - Article

C2 - 18360017

AN - SCOPUS:40149087517

VL - 31

SP - 43

EP - 50

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 1

ER -